Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,100 employees worldwide. Bio-Rad had revenues exceeding $2.3 billion in 2019.

Published Feb 13, 2025 4:15pm EST Transaction To Complement Bio-Rad’s Existing Digital PCR Portfolio and Accelerate Development of Next-Generation Digital PCR Solutions ...

Q2 2025 Management View Norman Schwartz, Chairman & CEO, indicated Bio-Rad delivered solid execution in Q2 2025, with both revenue and operating margin surpassing consensus expectations. Schwartz ...

Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.1 billion in 2017.

The CFX Opus Deepwell Dx Real-Time PCR System is the latest addition to the Bio-Rad portfolio of real-time PCR instruments. The system offers accurate and precise quantification with flexibility for ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...

Bio-Rad Laboratories Inc (BIO) reports a 2.1% sales increase and raises full-year guidance despite margin pressures and ...

Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms ...

In the first quarter of 2020, Bio-Rad witnessed solid revenue growth at both operating segments. Further, strength in many of its key product lines across major geographic regions buoyed optimism.

Investing.com -- Bio-Rad Laboratories, Inc. (NYSE: BIO) shares surged 12.7% after the life science research and clinical diagnostics company reported second quarter earnings that substantially ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies published this month, ahead of ...